Piramal Critical Care and BREPCO Gain MHRA Approval for NeoAtrico in the UK

Unknown Apr 02, 2026 1,200 Views

Piramal Critical Care, a business unit of Piramal Pharma Limited, and BREPCO have revealed that their innovative product, NeoAtrico, has obtained marketing consent from the UK's Medicines and Healthcare Products Regulatory Agency (MHRA). This is a major achievement towards establishing Pirama...